4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ADMA Biologics, Inc. (ADMA) operates in the Biotechnology industry and is headquartered in Ramsey, United States with about 640 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ADMA reported $510M in revenue and $147M in net income.
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments.
Interactive charts & full statements → Open the ADMA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $510M | $426M | $258M | $154M |
| Gross Profit | $293M | $220M | $89M | $35M |
| Operating Income (EBIT) | $191M | $139M | $22M | ($39M) |
| Net Income | $147M | $198M | ($28M) | ($66M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $114M | $139M | $134M | $122M | $115M |
| Gross Profit | $81M | $89M | $76M | $67M | $61M |
| Operating Income (EBIT) | $50M | $63M | $51M | $43M | $35M |
| Net Income | $45M | $49M | $36M | $34M | $27M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $624M | $489M | $329M | $348M | — |
| Total Liabilities | $147M | $140M | $194M | $196M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADMA viewer.
About TickerBase · Data methodology & sources